Ignite Creation Date:
2024-05-11 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06400251
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-05-03
Brief Title:
Testing Ipatasertib as Potentially Targeted Treatment in Cancers With AKT Genetic Changes MATCH - Subprotocol Z1K
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Refractory Multiple Myeloma |
| Advanced Lymphoma |
| Advanced Malignant Solid Neoplasm |
| Refractory Lymphoma |
| Refractory Malignant Solid Neoplasm |
Keywords: